157 related articles for article (PubMed ID: 3287971)
41. Newer antibiotics: their place in geriatric care. Part I.
Gleckman RA; Bergman MM
Geriatrics; 1986 Dec; 41(12):51-5. PubMed ID: 3465671
[TBL] [Abstract][Full Text] [Related]
42. Formulary evaluation of second-generation cephamycin derivatives using decision analysis.
Barriere SL
Am J Hosp Pharm; 1991 Oct; 48(10):2146-50. PubMed ID: 1781469
[TBL] [Abstract][Full Text] [Related]
43. Anaerobic infections in cancer patients--a retrospective analysis of clindamycin, tinidazole, doxycycline, cefoxitin and lamoxactam.
Lagast H; Klastersky J
Infection; 1982; 10(3):144-8. PubMed ID: 6213562
[TBL] [Abstract][Full Text] [Related]
44. [Efficiency of cefmetazole and cefoxitin in the treatment of sepsis caused by gram-negative bacteria].
Noguerado A; García-Monzón C; Martínez MC; Isasia T; Padilla B; Arribas I; Moreno MJ; Jiménez ML
Rev Clin Esp; 1988 Mar; 182(5):250-2. PubMed ID: 3041494
[No Abstract] [Full Text] [Related]
45. Comparison of cefoxitin, cefotetan and the combination of ampicillin with sulbactam in the therapy of polymicrobial infection in mice.
Brook I
J Antimicrob Chemother; 1994 Nov; 34(5):791-6. PubMed ID: 7706175
[TBL] [Abstract][Full Text] [Related]
46. Role of cephamycins in obstetrics and gynecology.
Sweet RL
J Reprod Med; 1990 Nov; 35(11 Suppl):1064-9. PubMed ID: 2277374
[TBL] [Abstract][Full Text] [Related]
47. Newer cephalosporins: lessons to be learned from clinical trials in intraabdominal infections.
Bumgardner GL; Simmons RL
Am J Surg; 1988 May; 155(5A):5-10. PubMed ID: 3287968
[TBL] [Abstract][Full Text] [Related]
48. Activities of cefoxitin and cefotetan against Mycobacterium fortuitum infections in mice.
Saito H; Sato K; Jin BW
Antimicrob Agents Chemother; 1984 Aug; 26(2):270-1. PubMed ID: 6592999
[TBL] [Abstract][Full Text] [Related]
49. Comparison of cefotetan versus cefoxitin for acute bacterial infections.
Horsch A
Chemioterapia; 1987 Jun; 6(2 Suppl):369-70. PubMed ID: 3334577
[No Abstract] [Full Text] [Related]
50. [Prospective and comparative study of cefoxitin and ceftizoxime in appendicitis surgery].
Sanz Villa N; Alvarez Bernaldo de Quirós M; Cortés Gómez MJ; Omeñaca C
An Esp Pediatr; 1997 Sep; 47(3):279-84. PubMed ID: 9499281
[TBL] [Abstract][Full Text] [Related]
51. [Clinical evaluation of moxalactam].
Acar JF
Sem Hop; 1983 Jun; 59(26):1990-3. PubMed ID: 6310793
[No Abstract] [Full Text] [Related]
52. Susceptibility of bacterial pathogens to cefotetan judged by MIC and disc tests.
Grimm H
J Antimicrob Chemother; 1983 Jan; 11 Suppl():37-43. PubMed ID: 6573324
[TBL] [Abstract][Full Text] [Related]
53. Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic.
Yu VL
Ann Intern Med; 1981 Jun; 94(6):784-5. PubMed ID: 6453542
[No Abstract] [Full Text] [Related]
54. Efficacy and cost implications of the new cephalosporins. Vancouver, British Columbia, Canada, August 21-22, 1987. Proceedings.
Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):687-746. PubMed ID: 3162651
[No Abstract] [Full Text] [Related]
55. Comparative pharmacokinetics of cefotetan and cefoxitin in patients undergoing hysterectomies and colorectal operations.
Quintiliani R; Nightingale CH; Stevens RC; Outman WR; Deckers PJ; Martens MG
Am J Surg; 1988 May; 155(5A):67-70. PubMed ID: 3163902
[TBL] [Abstract][Full Text] [Related]
56. Newer cephalosporins and cephamycins--a review.
Norrby R
Scand J Infect Dis Suppl; 1978; (13):83-7. PubMed ID: 356183
[TBL] [Abstract][Full Text] [Related]
57. [Comparative double-blind study of cefotetan and cefmetazole in patients with purulent peritonitis].
Tanimura H; Hikasa Y; Kobayashi N; Kato H; Sekiya T; Sato T; Saito T; Yoshida K; Huang W; Hashino H; Nakamura M; Deguchi K
Jpn J Antibiot; 1983 Feb; 36(2):369-90. PubMed ID: 6343664
[TBL] [Abstract][Full Text] [Related]
58. Moxalactam therapy for bacterial infections.
Winston DJ; Busuttil RW; Kurtz TO; Young LS
Arch Intern Med; 1981 Nov; 141(12):1607-12. PubMed ID: 6458253
[TBL] [Abstract][Full Text] [Related]
59. Enterococcal infections in patients treated with moxalactam.
Moellering RC
Rev Infect Dis; 1982; 4 Suppl():S708-11. PubMed ID: 6218588
[TBL] [Abstract][Full Text] [Related]
60. Cefotetan versus cefoxitin in the treatment of patients with biliary sepsis assessed by a biliary sepsis score.
Basoli A; Schietroma M; Fiocca F; Vigliardi G; Speranza V
Chemioterapia; 1988 Aug; 7(4):237-40. PubMed ID: 3180303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
